Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rhoen Klinikum AGRHKJF 82 Forward PE Ratio is 21.43 as of Sep. 03, 2026. GuruFocus rates RHKJF with a GF Score™ of 82/100 and a GF Value™ of $14.71. The stock has 5 warning signs investors should review. Among 318 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks worse than 60.38% on this metric.
Rhoen Klinikum AG (OTCPK:RHKJF) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Rhoen Klinikum AG Forward PE Ratio Related Terms
Rhoen Klinikum AG Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Rhoen Klinikum AG's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhoen Klinikum AG Forward PE Ratio Chart
Rhoen Klinikum AG Annual Data
Trend
2015-12
2018-12
2019-12
2024-12
2025-12
Forward PE Ratio
37.17
52.63
42.02
19.81
17.49
Rhoen Klinikum AG Quarterly Data
2015-12
2016-03
2018-03
2018-06
2018-09
2018-12
2019-03
2019-06
2019-09
2019-12
2020-03
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
2026-06
Forward PE Ratio
37.17
34.84
56.82
51.28
53.76
52.63
38.91
61.35
50.25
42.02
39.53
19.81
22.60
19.67
17.21
17.49
17.11
21.43
RHKJF vs HCA, THC, EHC: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhoen Klinikum AG Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Rhoen Klinikum AG's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Rhoen Klinikum AG (RHKJF) has a Forward PE Ratio of 21.43 as of Sep. 03, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Rhoen Klinikum AG and its competitors. According to the industry distribution chart, Rhoen Klinikum AG ranks #192 out of 318 companies in the Healthcare Providers & Services industry, placing it in the top 60.4%.
Is Rhoen Klinikum AG's Forward PE Ratio too high?
Rhoen Klinikum AG's current Forward PE Ratio is 21.43. The Healthcare Providers & Services industry median Forward PE Ratio is 16.87. Rhoen Klinikum AG's value of 21.43 is 27% above this industry median. Based on the distribution chart, Rhoen Klinikum AG ranks #192 out of 318 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Rhoen Klinikum AG has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Forward PE Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #192 out of 318 companies for Forward PE Ratio. This places Rhoen Klinikum AG in the lower half of its industry. The industry median Forward PE Ratio is 16.87. Rhoen Klinikum AG's value of 21.43 is 27% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 16.87, based on 318 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhoen Klinikum AG's current Forward PE Ratio of 21.43 is 27% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Rhoen Klinikum AG and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 16.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhoen Klinikum AG's current Forward PE Ratio is 21.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (RHKJF) has a current Forward PE Ratio of 21.43. The stock's GF Value™ is $14.71, compared to a current price of $15.30 — trading 4% above its estimated fair value. The current Forward PE Ratio is 21.43 and 27% above the Healthcare Providers & Services industry median of 16.87. Rhoen Klinikum AG's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Rhoen Klinikum AG (RHKJF), the current Forward PE Ratio is 21.43 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhoen Klinikum AG (RHKJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued.
The current stock price of $15.30 is trading 4% above its estimated GF Value™ of $14.71.
Key valuation signals for RHKJF:
Forward PE Ratio: 21.43
GF Value™: $14.71 vs. price of $15.30 (4% above fair value)
Industry Position: 27% above the Healthcare Providers & Services median (#192 of 318)
No single metric tells the full story. See the RHKJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
82GF Score
Get the complete analysis for RHKJF
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RHKJF has been successfully added to your 
